<DOC>
	<DOC>NCT01372865</DOC>
	<brief_summary>The primary objective will be to compare the impact of the study formulations on alergic rhinitis carriers.</brief_summary>
	<brief_title>A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Sign and date the informed consent form or, in case of subjects younger than 18 years, the document must also be signed by a legal guardian; ≥ 12 years old; Suffer from mild to moderated persistent alergic rhinitis; Total NIS scale score ≥ 4 points at the screening visit and within at least 4 of the 7 days before the randomization visit; Indication for use nasal corticosteroid; Present with alergic rhinitis symptoms for at least 2 years; May undergo a washout period of at least 2 weeks Patients with severe alergic rhinitis; Patients with severe comorbidities (at the investigator's criteria); Patients with mild to severe persistent asthma; Clinical history of infection of the airways 30 days before the study entry; Patients with structural changes causing nasal obstruction, such as pronounced nasal septum deviation, nasal polyps or any other type of nasal malformation; For female subjects, be pregnant or breastfeeding or planning to become pregnant or unwilling to use safe birth control methods during the study; subjects in need of other drugs to treat alergic rhinitis, such as antiimmunoglobulin E, immunotherapy, antileukotrienes, oral corticosteroids, inhalant corticosteroids, or any administration route other than cutaneous; Active smokers (use of cigarette, pipe, cigar or any other form of tobacco in any amount within the past 3 months before the study entry); Participation in another clinical study within the past 12 months;</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>